ONCAlert | Upfront Therapy for mRCC

CAR T-Cell Therapy VIEW MORE >>

In an interview with Targeted Oncology, Bianca D. Santomasso, MD, PhD, discussed the challenges with treating patients who develop neurotoxicity following treatment with new CAR T cells following her talk at the 2019 SOHO Annual Meeting. She also highlighted how the CAR T cells are changing the treatment landscape for patients with lymphomas.

Latest JournalAll Journals >>

Copyright © TargetedOnc 2019 Intellisphere, LLC. All Rights Reserved.